Market Overview

Benzinga's Top Initiations

Related TKMR
Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines
UPDATE: Dicerna Announces License Agreement With Tekmira
Making Money With Charles Payne: 10/24/14 (Fox Business)
Related SYRG
Imperial Capital Releases Its 'Best Ideas' With An Upside Potential Of More Than 30%
Imperial Capital Offers Best Ideas In Equity Research: American Airlines, Intel And More

Analysts at Leerink Partners initiated coverage on Tekmira Pharmaceuticals (NASDAQ: TKMR) with a Outperform rating. The target price for Tekmira Pharmaceuticals is set to $25. Tekmira Pharmaceuticals' shares closed at $18.08 on Friday.

Canaccord Genuity initiated coverage on shares of Synergy Resources (AMEX: SYRG) with a Buy rating. The target price for Synergy Resources is set to $17. Synergy Resources' shares closed at $12.78 on Friday.

Analysts at JP Morgan initiated coverage on shares of Intersect ENT (NASDAQ: XENT) with a Overweight rating. The target price for Intersect ENT is set to $22. Intersect ENT's shares closed at $15.05 on Friday.

Jefferies initiated coverage on shares of Townsquare Media (NYSE: TSQ) with a Buy rating. The target price for Townsquare Media is set to $17. Townsquare Media's shares closed at $11.19 on Friday.

Latest Ratings for TKMR

DateFirmActionFromTo
Nov 2014Stifel NicolausMaintainsBuy
Oct 2014Leerink SwannDowngradesOutperformMarket Perform
Aug 2014Leerink PartnersInitiates Coverage onOutperform

View More Analyst Ratings for TKMR
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (TKMR + SYRG)

Around the Web, We're Loving...

Get Benzinga's Newsletters